The MIS Turnkey Solution

Comprehensive Imaging Solutions for Urology

1.4 million men will be diagnosed with prostate cancer each year.Prostate cancer care is rapidly evolving, and PSMA PET/CT has become the new standard for staging, recurrence detection, and personalized treatment planning. Yet most urology practices rely on external imaging centers, voiding gaps in continuity of care, delays, and lost revenue.

MIS Eliminates These Barriers

We deliver a complete, end-to-end molecular imaging solution, customized for urology practices ready to advance their prostate cancer care.

Why Urology Practices Need PSMA PET/CT

  • Detect metastatic disease earlier and more accurately
  • Precisely localize recurrence at very low PSA levels
  • Improve surgical and radiation planning
  • Optimize systemic therapy decisions
  • Enhance patient retention, satisfaction, and outcomes
  • Achieve expedited patient scan results

1. American Cancer Society. (2024, September 27). Cancer in men: prostate cancer is #1 for 118 countries worldwide. American Cancer Society. Retrieved from https://www.cancer.org/research/acs-research-news/prostate-cancer-is-number-1-for-118-countries-worldwide.html

Benefits for Urology Practices

MIS: Your Turnkey Imaging Partner

MIS handles every detail required to launch and operate a high-performing molecular imaging program

  • Business & Feasibility Analysis

  • Project Management & Construction Oversight

  • Regulatory & Facility Setup

  • Equipment & Technology

  • Radiotracer Logistics

  • Staffing & Clinical Operations

  • Billing, Coding & Reimbursement

  • Ongoing Quality & Performance Management

Ready to Elevate Your Urology Practice?

Bring PSMA PET/CT and advanced molecular imaging in-house, without the burden. Partner with MIS for a seamless, profitable, clinically superior imaging solution.